The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) EBITDA
The Cooper Companies, Inc.'s EBITDA for fiscal 2025 was $1.1B, unchanged from fiscal 2024. Over the twelve months to 31 July 2026 it was $928.2M. Over the past ten years it has ranged from $428.1M (fiscal 2015) to $1.1B (fiscal 2024); the current reading is higher than 91% of that period. The Cooper Companies, Inc. ranks 8th of 50 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $1.1B | (1.90%) |
| FY2024 | $1.1B | 19.98% |
| FY2023 | $900.8M | 5.52% |
| FY2022 | $853.7M | 4.74% |
| FY2021 | $815.1M | 36.10% |
| FY2020 | $598.9M | (27.63%) |
| FY2019 | $827.5M | 22.01% |
| FY2018 | $678.2M | 9.83% |
| FY2017 | $617.5M | 18.20% |
| FY2016 | $522.4M | 22.03% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jul 2026 | $316.7M | 391.77% |
| Apr 2026 | $64.4M | (79.11%) |
| Jan 2026 | $308.3M | 29.10% |
| Oct 2025 | $238.8M | (11.91%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| SOLV Solventum Corporation compare | $2.6B |
| BAX Baxter International Inc. compare | $1.5B |
| COO The Cooper Companies, Inc. | $928.2M |
| ALGN Align Technology, Inc. compare | $802.0M |
| ATR AptarGroup, Inc. compare | $784.6M |
| BLCO Bausch + Lomb Corporation compare | $749.0M |
| TFX Teleflex Incorporated compare | $256.2M |
| RGEN Repligen Corporation compare | $161.0M |
| AVTR Avantor, Inc. compare | $124.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on COO
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement